Pharm Tech Agenda 2011.11.10: Difference between revisions
Jump to navigation
Jump to search
m Created page with "== Topics to be discussed == === Questions === * ? * ? === ? === === ? ===" |
No edit summary |
||
| Line 1: | Line 1: | ||
== Topics to be discussed == | == Topics to be discussed == | ||
=== current state of the medication Documentation white paper (Marco, Ana)=== | |||
=== Questions === | === Questions === | ||
* | * existing use cases - do we have enough compelling use cases ? (Marco, Tom) | ||
* Comparison to PCC QED and to PCC RECON (Marco) | |||
* '''Decision''' on | |||
:: *how to proceed, | |||
::* distribution of workload, | |||
::* timetable, | |||
::* is it going to be a CP? | |||
::::* If yes, a CP to what profile, PCC Medication Reconciliation? | |||
* Variations ? | |||
=== ? === | === ? === | ||
Revision as of 05:15, 3 November 2011
Topics to be discussed
current state of the medication Documentation white paper (Marco, Ana)
Questions
- existing use cases - do we have enough compelling use cases ? (Marco, Tom)
- Comparison to PCC QED and to PCC RECON (Marco)
- Decision on
- *how to proceed,
- distribution of workload,
- timetable,
- is it going to be a CP?
- If yes, a CP to what profile, PCC Medication Reconciliation?
- Variations ?